Forbes - What To Know About Remdesivir

Plus: New rules for the Oscars

A lot of new information came out today about a drug called remdesivir that can potentially treat COVID-19. Three new studies came out; one from China, one from the National Institutes of Health, and one from Gilead, the company that manufactures the drug. What does all this new info mean? Much if it is still preliminary, but two of the studies found that remdesivir can help COVID-19 patients and shorten the length of time in the hospital. Dr. Anthony Fauci said today that the drug will be the “standard of care.” But there are some caveats. The Gilead trial didn’t have a placebo, which is important for measuring the effect of the drug. And the Chinese paper published in The Lancet found no benefit to remdesivir at all. More data will be coming out in the next few weeks, and we’ll be sure to keep you updated.

Business

Stocks moved higher at the end of the day after Gilead reported positive remdesivir data.

People spending less time in cars means podcasts aren’t as popular.

President Trump signed an executive order to keep meat plants open despite COVID-19 outbreaks.

President Trump says he will sign an executive order to keep meat plants open; industry leaders warn of a #food shortage,# but workers are getting sick from COVID-19.

Tesla founder Elon Musk made his thoughts on reopening the economy known on Twitter.

Science & Health

New York is hiring a thousand healthcare workers to begin contact tracing, but what does that really mean?

An infectious disease expert explains why scientists need to work together across borders.

The UN says that lockdowns are preventing access to birth control around the world, which could lead to millions of unintended pregnancies.

Speaking of birth control: here’s what to do if you’re due to get your implant soon but the doctor’s office is closed.

Tracker of the day

Coronavirus Layoffs: Lyft and Boeing are two of the latest companies to have big layoffs.